Search research articles
Contact Us
Filters
Showing results (101-110 of 186) with videos related to
Page
of 19
Sort By:
Pharmacogenetics and Genomics
|
December 5, 2013
A pharmacogenetic study of aldehyde oxidase I in patients treated with XK469
Jacqueline Ramírez, Tae Won Kim, Wanqing Liu, et al.
Archives of Toxicology
|
January 20, 2016
Association between CYP2E1 polymorphisms and risk of differentiated thyroid carcinoma
Lucia Pellé, Monica Cipollini, Roman Tremmel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 17, 2022
Tumor Immunogenomic Features Determine Outcomes in Patients with Metastatic Colorectal Cancer Treated with Standard-of-Care Combinations of Bevacizumab and Cetuximab
Federico Innocenti, Akram Yazdani, Naim Rashid, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 30, 2009
Genotype-driven phase I study of irinotecan administered in combination with fluorouracil/leucovorin in patients with metastatic colorectal cancer
Giuseppe Toffoli, Erika Cecchin, Giampiero Gasparini, et al.
Cancer Research
|
November 3, 2018
Genetic Variants of <i>VEGFA</i> and <i>FLT4</i> Are Determinants of Survival in Renal Cell Carcinoma Patients Treated with Sorafenib
Daniel J Crona, Andrew D Skol, Veli-Matti Leppänen, et al.
Cancer Causes & Control : CCC
|
May 20, 2019
Influence of genetic variation in the vitamin D pathway on plasma 25-hydroxyvitamin D<sub>3</sub> levels and survival among patients with metastatic colorectal cancer
Chen Yuan, Lindsay Renfro, Pratibha B Ambadwar, et al.
Epigenetics
|
April 12, 2022
Evaluation of methylated DCR1 as a biomarker for response to adjuvant irinotecan-based therapy in stage III colon cancer: cancer and leukaemia Group B 89803 (Alliance)
Lynn Symonds, Ming Yu, YuHong Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 25, 2014
Dose-finding and pharmacokinetic study to optimize the dosing of irinotecan according to the UGT1A1 genotype of patients with cancer
Federico Innocenti, Richard L Schilsky, Jacqueline Ramírez, et al.
Clinical Pharmacology and Therapeutics
|
December 24, 2019
A New Liver Expression Quantitative Trait Locus Map From 1,183 Individuals Provides Evidence for Novel Expression Quantitative Trait Loci of Drug Response, Metabolic, and Sex-Biased Phenotypes
Amy S Etheridge, Paul J Gallins, Dereje Jima, et al.
Research Square
|
April 1, 2024
Gene expression biomarkers differentiate overall survival of colorectal cancer upon targeted therapies
Akram Yazdani, Azam Yazdani, Raul Mendez-Giraldez, et al.
Page
of 19
Search research articles
Search
Showing results (101-110 of 186) with videos related to
Sort By:
Page
of 19
Pharmacogenetics and Genomics
|
December 5, 2013
A pharmacogenetic study of aldehyde oxidase I in patients treated with XK469
Jacqueline Ramírez, Tae Won Kim, Wanqing Liu, et al.
Archives of Toxicology
|
January 20, 2016
Association between CYP2E1 polymorphisms and risk of differentiated thyroid carcinoma
Lucia Pellé, Monica Cipollini, Roman Tremmel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 17, 2022
Tumor Immunogenomic Features Determine Outcomes in Patients with Metastatic Colorectal Cancer Treated with Standard-of-Care Combinations of Bevacizumab and Cetuximab
Federico Innocenti, Akram Yazdani, Naim Rashid, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 30, 2009
Genotype-driven phase I study of irinotecan administered in combination with fluorouracil/leucovorin in patients with metastatic colorectal cancer
Giuseppe Toffoli, Erika Cecchin, Giampiero Gasparini, et al.
Cancer Research
|
November 3, 2018
Genetic Variants of <i>VEGFA</i> and <i>FLT4</i> Are Determinants of Survival in Renal Cell Carcinoma Patients Treated with Sorafenib
Daniel J Crona, Andrew D Skol, Veli-Matti Leppänen, et al.
Cancer Causes & Control : CCC
|
May 20, 2019
Influence of genetic variation in the vitamin D pathway on plasma 25-hydroxyvitamin D<sub>3</sub> levels and survival among patients with metastatic colorectal cancer
Chen Yuan, Lindsay Renfro, Pratibha B Ambadwar, et al.
Epigenetics
|
April 12, 2022
Evaluation of methylated DCR1 as a biomarker for response to adjuvant irinotecan-based therapy in stage III colon cancer: cancer and leukaemia Group B 89803 (Alliance)
Lynn Symonds, Ming Yu, YuHong Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 25, 2014
Dose-finding and pharmacokinetic study to optimize the dosing of irinotecan according to the UGT1A1 genotype of patients with cancer
Federico Innocenti, Richard L Schilsky, Jacqueline Ramírez, et al.
Clinical Pharmacology and Therapeutics
|
December 24, 2019
A New Liver Expression Quantitative Trait Locus Map From 1,183 Individuals Provides Evidence for Novel Expression Quantitative Trait Loci of Drug Response, Metabolic, and Sex-Biased Phenotypes
Amy S Etheridge, Paul J Gallins, Dereje Jima, et al.
Research Square
|
April 1, 2024
Gene expression biomarkers differentiate overall survival of colorectal cancer upon targeted therapies
Akram Yazdani, Azam Yazdani, Raul Mendez-Giraldez, et al.
Page
of 19